SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-027966
Filing Date
2024-03-07
Accepted
2024-03-07 16:15:29
Documents
55
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mack-20231231.htm   iXBRL 10-K 1128470
2 EX-4.5 mack-ex4_5.htm EX-4.5 43570
3 EX-4.5(1) mack-ex4_51.htm EX-4.5(1) 12012
4 EX-21.1 mack-ex21_1.htm EX-21.1 3711
5 EX-23.1 mack-ex23_1.htm EX-23.1 4054
6 EX-31.1 mack-ex31_1.htm EX-31.1 12737
7 EX-31.2 mack-ex31_2.htm EX-31.2 12737
8 EX-32.1 mack-ex32_1.htm EX-32.1 6345
9 EX-32.2 mack-ex32_2.htm EX-32.2 6345
10 EX-97.1 mack-ex97_1.htm EX-97.1 54916
  Complete submission text file 0000950170-24-027966.txt   5113672

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mack-20231231.xsd EX-101.SCH 783539
57 EXTRACTED XBRL INSTANCE DOCUMENT mack-20231231_htm.xml XML 741480
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35409 | Film No.: 24730299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)